Pentoxifylline (PD-Rx Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Pentoxifylline drug offered from PD-Rx Pharmaceuticals, Inc.. This Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | PD-Rx Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Pentoxifylline |
SUBSTANCE NAME: | PENTOXIFYLLINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-11-15 |
END MARKETING DATE: | 0000-00-00 |
Pentoxifylline HUMAN PRESCRIPTION DRUG Details:
Item Description | Pentoxifylline from PD-Rx Pharmaceuticals, Inc. |
LABELER NAME: | PD-Rx Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 2010-11-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43063-188_50ff430c-16e2-2b8e-e054-00144ff88e88 |
PRODUCT NDC: | 43063-188 |
APPLICATION NUMBER: | ANDA075028 |
Other PENTOXIFYLLINE Pharmaceutical Manufacturers / Labelers: